Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Richard C. Koya, M.D., Ph.D.
Richard C. Koya, M.D., Ph.D.

Affiliation(s):

Assistant Professor, Department of Surgery, Surgical Oncology
Member, JCCC Tumor Immunology Program Area

Contact Information:

Phone:
(310) 825-2676
(310) 267-3315
Email:

Scientific Interest(s):

Dr. Richard C. Koya conducts laboratory and clinical research focused on immunotherapy and targeted specific therapy of cancer. Koya’s research interests include gene vector design, molecular imaging, new approaches to enhance anti-cancer T-lymphocyte responses, advanced immune monitoring and understanding of cancer biology for therapeutic translation.

Selected Cancer-Related Publications:

Ma C, Fan R, Ahmad H, Shi Q, Comin-Anduix B, Chodon T, Koya RC, Liu CC, Kwong GA, Radu CG, Ribas A, Heath JR. A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cells. Nat Med. 2011 Jun;17(6):738-43. Epub 2011 May 22.

Koya RC, Mok S, Comin-Anduix B, Chodon T, Radu CG, Nishimura MI, Witte ON, Ribas A. Kinetic phases of distribution and tumor targeting by T cell receptor engineered lymphocytes inducing robust antitumor responses. Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14286-91. Epub 2010 Jul 12.

Brusko TM, Koya RC, Zhu S, Lee MR, Putnam AL, McClymont SA, Nishimura MI, Han S, Chang LJ, Atkinson MA, Ribas A, Bluestone JA. Human antigen-specific regulatory T cells generated by T cell receptor gene transfer. PLoS One. 2010 Jul 22;5(7):e11726.

Nazarian R, Shi H, Wang Q, Kong X, Koya RC, Lee H, Chen Z, Lee MK, Attar N, Sazegar H, Chodon T, Nelson SF, McArthur G, Sosman JA, Ribas A, Lo RS. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature. 2010 Dec 16;468(7326):973-7. Epub 2010 Nov 24.

Tumeh PC, Koya RC, Chodon T, Graham NA, Graeber TG, Comin-Anduix B, Ribas A. The impact of ex vivo clinical grade activation protocols on human T-cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapy. J Immunother. 2010 Oct;33(8):759-68.